Bayer (FRA:BAYN) Given a €124.00 Price Target at Commerzbank

Commerzbank set a €124.00 ($147.62) price target on Bayer (FRA:BAYN) in a research note issued to investors on Tuesday, January 9th. The firm currently has a buy rating on the healthcare company’s stock.

Several other equities analysts also recently weighed in on the company. Warburg Research set a €121.00 ($144.05) price target on Bayer and gave the company a buy rating in a report on Wednesday, September 13th. JPMorgan Chase & Co. restated a buy rating on shares of Bayer in a report on Friday, October 20th. Jefferies Group set a €132.00 ($157.14) price target on Bayer and gave the company a buy rating in a report on Monday, September 18th. equinet set a €118.00 ($140.48) price target on Bayer and gave the company a buy rating in a report on Friday, September 15th. Finally, BNP Paribas set a €130.00 ($154.76) price objective on Bayer and gave the company a buy rating in a research report on Monday, September 25th. One analyst has rated the stock with a sell rating, seven have assigned a hold rating and fourteen have assigned a buy rating to the stock. The company presently has an average rating of Buy and a consensus price target of €121.67 ($144.84).

Bayer (FRA:BAYN) opened at €103.72 ($123.48) on Tuesday. The stock has a market capitalization of $85,850.00 and a price-to-earnings ratio of 27.81. Bayer has a twelve month low of €99.69 ($118.68) and a twelve month high of €123.82 ($147.40).

TRADEMARK VIOLATION WARNING: “Bayer (FRA:BAYN) Given a €124.00 Price Target at Commerzbank” was first reported by BBNS and is the sole property of of BBNS. If you are viewing this piece on another domain, it was copied illegally and reposted in violation of international copyright & trademark laws. The legal version of this piece can be accessed at https://baseballnewssource.com/markets/bayer-bayn-pt-set-at-124-00-by-commerzbank/1824138.html.

About Bayer

Bayer Aktiengesellschaft operates as a life science company worldwide. The company operates through Pharmaceuticals, Consumer Health, Crop Science, Animal Health, and Covestro segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents.

Analyst Recommendations for Bayer (FRA:BAYN)

Receive News & Ratings for Bayer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bayer and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Rumor: Milwaukee Brewers Offer Yu Darvish Contract
Rumor: Milwaukee Brewers Offer Yu Darvish Contract
Report: 20-Second Clock and Limit on Mound Visits Rejected by MLBPA
Report: 20-Second Clock and Limit on Mound Visits Rejected by MLBPA
Christian Yelich’s Agent Says Relationship with Marlins is Broken
Christian Yelich’s Agent Says Relationship with Marlins is Broken
Houston Astros Add Starter to Rotation
Houston Astros Add Starter to Rotation
Sources: Mets Bringing Back Jay Bruce with Three-Year Deal
Sources: Mets Bringing Back Jay Bruce with Three-Year Deal
Justin Morneau Former Star With Twins and AL MVP Retires
Justin Morneau Former Star With Twins and AL MVP Retires


Leave a Reply

 
© 2006-2018 BBNS.